Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1997 Feb 10;136(3):659–668. doi: 10.1083/jcb.136.3.659

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Quantitative immunofluorescence analyses on the levels of CHO1/MKLP1 within interphase neuroblastoma cells (Inter), cells undergoing mitotis (Mito), cells treated with retinoic acid (RA), and cells treated with cAMP (cAMP). Protein levels were measured in arbitrary fluorescence units (AFU). Ten cells were examined under each condition, and a mean ± SD was obtained for each condition. Statistical analyses using the student's t test indicate no statistical difference between interphase and mitotic cells (P < 0.687), but marked differences between retinoic acid– treated cells and the other experimental conditions (P < 0.001) and between cAMP-treated cells and the other experimental conditions (P < 0.0005). Retinoic acid–treated cells had significantly higher levels of CHO1/MKLP1 while cAMP-treated cultures had significantly lower levels of CHO1/MKLP1.